Skip to content
10-Q

Quarterly Report

ImmunityBio, Inc. IBRX

0001326110-25-000139

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 984.97M sh
Shares Diluted Q3 2025 · Sep 30, 2025 946.6M sh
Shares Diluted Q3 2025 · Sep 30, 2025 896.34M sh
Shares Diluted Q3 2025 · Sep 30, 2024 697.96M sh
Shares Diluted Q3 2025 · Sep 30, 2024 688.94M sh
Capex Q3 2025 · Sep 30, 2025 $2.94M
Capex Q3 2025 · Sep 30, 2024 $4.78M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$234.56M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$306.09M
Short Term Debt Q3 2025 · Sep 30, 2025 $2.6M
Short Term Debt Q3 2025 · Dec 31, 2024 $1.25M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $60.24M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $143.43M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $111.97M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$524.32M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$489.1M
Current Liabilities Q3 2025 · Sep 30, 2025 $57.13M
Current Liabilities Q3 2025 · Dec 31, 2024 $54.94M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.04B
Total Liabilities Q3 2025 · Dec 31, 2024 $871.06M
Current Assets Q3 2025 · Sep 30, 2025 $329.5M
Current Assets Q3 2025 · Dec 31, 2024 $184.59M
Total Assets Q3 2025 · Sep 30, 2025 $518.99M
Total Assets Q3 2025 · Dec 31, 2024 $382.93M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.07
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.32
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.14
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.53
Eps Basic Q3 2025 · Sep 30, 2025 −$0.07
Eps Basic Q3 2025 · Sep 30, 2025 −$0.32
Eps Basic Q3 2025 · Sep 30, 2024 −$0.12
Eps Basic Q3 2025 · Sep 30, 2024 −$0.52
Net Income Q3 2025 · Sep 30, 2025 −$67.25M
Net Income Q3 2025 · Sep 30, 2025 −$289.45M
Net Income Q3 2025 · Sep 30, 2024 −$85.73M
Net Income Q3 2025 · Sep 30, 2024 −$354.4M
Operating Income Q3 2025 · Sep 30, 2025 −$55.63M
Operating Income Q3 2025 · Sep 30, 2025 −$191.34M
Operating Income Q3 2025 · Sep 30, 2024 −$80.25M
Operating Income Q3 2025 · Sep 30, 2024 −$274.78M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $177K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $371K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $0
Cost Of Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2025 $32.06M
Revenue Q3 2025 · Sep 30, 2025 $75M
Revenue Q3 2025 · Sep 30, 2024 $6.11M
Revenue Q3 2025 · Sep 30, 2024 $7.19M